Tilray Brands Inc

NASDAQ: TLRY
$1.66
-$0.07 (-4.0%)
Closing Price on June 28, 2024

TLRY Articles

The October 31 short interest data have been compared with the previous figures, and short interest in most of these selected marijuana stocks increased.
Here is a look at how some of the individual legalized cannabis stocks were assigned coverage by Cantor Fitzgerald.
Tuesday's top analyst upgrades, downgrades and initiations included Amgen, Beyond Meat, Cisco, Home Depot, Microsoft, RingCentral, Shake Shack, Tilray, Uber, Under Armour and U.S. Steel.
Jefferies is out with a report cutting some price targets and ratings that comes as kind of a surprise, given the sharp sell-off in the cannabis industry over the past two months.
Friday's top analyst upgrades, downgrades and initiations included Apple, Canopy Growth, CrowdStrike, Delta Air Lines, Johnson & Johnson, Rio Tinto, Roku, Square, Tilray and Twilio.
Cannabis stocks took a big hit on Thursday after Hexo gave an update on its fourth-quarter and full-year guidance.
The top analyst upgrades, downgrades and initiations for Friday included Apple, Aurora Cannabis, Constellation Brands, Etsy, Marathon Oil, Roku, Square and Tilray.
Tilray released its second quarter financial results after the markets closed on Tuesday. The company said that it had a net loss of $0.36 per share and $45.9 million in revenue, compared with...
Tilray is scheduled to release its second-quarter financial results after the markets close on Tuesday, and analysts anticipate a net loss.
The top analyst upgrades, downgrades and initiations seen on Wednesday included Apple, Canopy Growth, Cheniere, CSX, Johnson & Johnson, Motorola, Slack, Tilray and VMware.
A group called Innovation Shares is launching the first passively managed pure-play ETF that targets investing in cannabis.
The top analyst upgrades, downgrades and initiations on Tuesday included Agilent Technologies, Allergan, Beyond Meat, Canopy Growth, Dollar Tree, Facebook, Luckin Coffee, Lyft, Mylan, Symantec,...
The Church of England has lifted its ban on investing in companies that sell medical marijuana.
Tilray shares jumped on Monday after the firm announced that it had signed a letter of intent with its largest stockholder Privateer Holdings.
Tilray shares pulled back after its first-quarter earnings report despite a solid beat on the top line.